ID,Drug,Disease,Edge_Inference_type Rx00069,coagulation factor viia (recombinant),hemorrhagic complications,Primary indication Rx00069,coagulation factor viia (recombinant),hemophilia A,Primary indication Rx00069,coagulation factor viia (recombinant),hemophilia B,Primary indication Rx00069,coagulation factor viia (recombinant),Glanzmann's thrombasthenia,Secondary indication Rx00069,coagulation factor viia (recombinant),bleeding,Secondary indication Rx00069,coagulation factor viia (recombinant),intracranial hemorrhage,Secondary indication Rx00069,coagulation factor viia (recombinant),diffuse alveolar hemorrhage,Secondary indication Rx00069,coagulation factor viia (recombinant),bleeding episodes,Secondary indication Rx00069,coagulation factor viia (recombinant),Factor VII Deficiency,Secondary indication Rx00069,coagulation factor viia (recombinant),acquired hemophilia,Secondary indication